Back to Trades
Sell4
Heartflow, Inc.
HTFL
Total Value
$2.4M
Net $1.6M sold
Sales
$1.6M
1 transaction
Company Information
- Company Name
- Heartflow, Inc.
- Ticker Symbol
- HTFL
- CIK
- 0001464521
Insider Information
- Name
- Rogers Campbell
- Role
- Chief Medical Officer
- Location
- MOUNTAIN VIEW, CA
Officer
Filing Details
- Filing Date
- Feb 17, 2026
- Transaction Date
- Feb 12, 2026
- Accession Number
- 0001464521-26-000018
- Form Type
- 4
- Net Trading Amount
- -$1.6M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 12, 2026 | Common Stock | 19,401 | $2.22 | Exercise | $43.1K |
| Feb 12, 2026 | Common Stock | 39,709 | $8.33 | Exercise | $330.8K |
| Feb 12, 2026 | Common Stock | 7,906 | $2.22 | Exercise | $17.6K |
| Feb 12, 2026 | Common Stock | 65,153 | $24.49 | Sale | $1.6M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 12, 2026 | Derivative | 39,709 | $8.33 | Exercise | $330.8K |
| Feb 12, 2026 | Derivative | 19,401 | $2.22 | Exercise | $43.1K |
| Feb 12, 2026 | Derivative | 7,906 | $2.22 | Exercise | $17.6K |
Footnotes
- (F1)The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
- (F2)The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
- (F3)Includes the sale of 17,538 shares of common stock held and the option exercise and sale of 47,615 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
- (F4)This transaction was executed in multiple trades at price ranging from $22.90 to $26.51. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- (F5)These stock options are fully exercisable.
- (F6)The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.